Skip to main content

Advertisement

Log in

Thymectomy and Antibodies to Acetylcholine Receptors in Myasthenia Patients during the Early Post-Operative Period

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

A total of 21 patients with myasthenia underwent thymectomy with removal of hyperplastic thymus tissue. Thymectomy in 14 patients was performed using a thoracoscopic approach and in seven via thoracotomy. Serum anti-acetylcholine receptor levels were assayed after surgery and demonstrated increases in both groups of patients in the early post-operative period (one month) as compared with the pre-operative period. It is suggested that these changes represent the immune response to the stress situation associated with surgical intervention. The increase in antibody levels was somewhat greater in patients with thoracotomy access, which may be associated with the greater volume of tissue removed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. P. S. Vetshev, A. G. Sanadze, D. V. Sidnev, et al., “Antibodies to titin in patients with myasthenic and nonmyasthenic thymoma,” Khirurgiya, 6, 53–56 (2007).

    Google Scholar 

  2. M. I. Kuzin, and B. M. Gekht, Myasthenia [in Russian], Meditsina, Moscow (1996).

    Google Scholar 

  3. A. G. Sanadze, B. M. Gekht, D. V. Sidnev, et al., “Antibodies to acetylcholine receptors in the diagnosis of myasthenia and other forms associated with pathology of neuromuscular transmission,” Nevrol. Zh., 8, No. 1, 19–20 (2003).

    Google Scholar 

  4. D. V. Sidnev, M. Yu. Karganov, N. I. Shcherbakova, et al., “Antibodies to acetylcholine receptors in patients with different clinical forms of myasthenia and Lambert–Eaton myasthenic syndrome,” Zh. Nevrol. Psikhiat., 106, No. 1, 53–55 (2006).

    CAS  Google Scholar 

  5. D. V. Sidnev, A. G. Sanadze, N. I. Shcherbakova, and A. V. Kondrat’ev, “Antibodies to titin in assessing the efficacy of thymectomy in patients with generalized myasthenia without thymoma,” Grud. Serd.-Sosud. Khir., No. 4, 48–50 (2007).

    Google Scholar 

  6. D. V. Sidnev, A. G. Sanadze, S. I. Dedaev, et al., “Antibodies to acetylcholine receptors in assessing the efficacy of the pathogenetic treatment of patients with myasthenia,” Zh. Nevrol. Psikhiat., No. 12, 74–77 (2010).

    Google Scholar 

  7. D. F. Skripnichenko and M. M. Shevnyuk, The Diagnosis and Treatment of Myasthenia [in Russian], Zdorov’ya, Kiev (1991).

    Google Scholar 

  8. V. P. Kharchenko, D. S. Sarkisov, P. S. Vetshev, et al., Thymus Diseases [in Russian], Triada-X, Moscow (1998).

    Google Scholar 

  9. A. P. Kalinin, N. A. Maistrenko, and P. S. Vetshev (eds.), Surgical Endocrinology [in Russian], Piter, Moscow, St. Petersburg (2004), pp. 404–462.

  10. A. Blalock, “Tumors of the thymic region and myasthenia gravis,” Am. J. Surg., 57, 149–150 (1941).

    Article  Google Scholar 

  11. B. M. Conti-Fine, M. Milani, and H. J. Kaminski, “Myasthenia gravis: past, present and future,” J. Clin. Invest., 116, No. 11, 2843–2854 (2006).

    Article  PubMed  CAS  Google Scholar 

  12. P. C. Dau, J. M. Lindsrom, C. K. Cassel, et al., “Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis,” J. Neurol. Sci., 29, No. 5, 734–738 (1993).

    Google Scholar 

  13. D. Drachman, R. Adams, L. Josifek, and S. Self, “Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis,” New Eng. J. Med., 307, 769–773 (1982).

    Article  PubMed  CAS  Google Scholar 

  14. G. S. Gronseth and R. J. Barohn, “Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology,” Neurology, 55, 7–15 (2000).

    Article  PubMed  CAS  Google Scholar 

  15. R. Hohlfeld, A. Melms, C. Schneider, et al., “Therapy of myasthenia gravis and myasthenic syndromes,” in: Neurological Disorders: Course and Treatment, T. Brandt et al. (eds.), Elsevier, Amsterdam (2003), pp. 1341–1362.

  16. A. Jaretzki 3rd, R. Barohn, R. M. Ernstoff, et al., “Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America,” Neurology, 55, 16–23 (2000).

    Article  PubMed  Google Scholar 

  17. K. Kagotani, Y. Monden, K. Nakahara, et al., “Anti-acetylcholine receptor antibody titer with extended thymectomy in myasthenia gravis,” J. Thorac. Cardiovasc. Surg., 90, No. 1, 7–12 (1985).

    PubMed  CAS  Google Scholar 

  18. G. Keanes, “The results of thymectomy in myasthenia gravis,” Brit. Med. J., No. 2, 611–616 (1949).

    Article  Google Scholar 

  19. J. C. Keesey, “Clinical evaluation and management of myasthenia gravis,” Muscle Nerve, 29, No. 4, 484–505 (2004).

    Article  PubMed  Google Scholar 

  20. S. G. Khicha, L. R. Kaiser, and J. B. Sharger, “Extended transcervical thymectomy in the treatment of myasthenia gravis,” Ann. N.Y. Acad. Sci., 1132, 336–343 (2008).

    Google Scholar 

  21. J. B. Kuks, H. J. Oosterhuis, P. C. Limburg, and T. H. The, “Antiacetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis,” Clin. Correlation J. Autoimmun., 4, No. 2, 197–211 (1991).

    Google Scholar 

  22. J. Lindstrom and E. H. Lambert, “Content of acetylcholine receptor and antibodies bound to receptor to myasthenia gravis, experimental autoimmune myasthenia gravis and Eaton–Lambert syndrome,” Neurology, 28, 130–138 (1978).

    Article  PubMed  CAS  Google Scholar 

  23. J. Newsom-Davis, G. Cutter, G. Wolfe, et al., “Status of the thymectomy trial for nonthymomatous myasthenia gravis. Patients receiving prednisone,” Ann. N.Y. Acad. Sci., 1132, 344–347 (2008).

    Article  PubMed  CAS  Google Scholar 

  24. H. J. Oosterhuis, P. C. Limburg, E. Hummel-Tapell, et al., “Antiacetylcholine receptor antibodies in myasthenia gravis. Part 3. The effect of thymectomy,” J. Neurol. Sci., 69, No. 3, 335–343 (1985).

    Article  PubMed  CAS  Google Scholar 

  25. P. M. Pego Fernandez, J. R. Milanez de Campos, J. Biscegli, et al., “Thymectomy by partial sternotomy for the treatment of myasthenia gravis,” Ann. Thorac. Surg., 74, 203–208 (2002).

    Google Scholar 

  26. J. C. Ruckert, M. Ismail, M. Swierz, et al., “Thoracoscopic thymectomy with the Da Vinci Robotic System for myasthenia gravis,” Ann. N.Y. Acad. Sci., 1132, 329–335 (2008).

    Article  PubMed  Google Scholar 

  27. F. Schumm, A. Fateh-Moghadam, and J. Dichgans, “Correlation of acetylcholine receptor antibodies and clinical severity of myasthenia gravis in combined immunosuppressive therapy,” Eur. Arch. Psychiat. Neurol. Sci., 234, No. 4, 224–230 (1984).

    Article  CAS  Google Scholar 

  28. N. Shibuya, T. Sato, M. Osame, et al., “Immunoadsorption therapy for myasthenia gravis,” J. Neurol. Neurosurg. Psychiat., 57, No. 5, 578–581 (1994).

    Article  PubMed  CAS  Google Scholar 

  29. J. R. Sonett and A. Jaretzki III, “Thymectomy for nonthymomatous myasthenia gravis: A critical analysis,” Ann. N.Y. Acad. Sci., 1132, 315–328 (2008).

    Article  PubMed  Google Scholar 

  30. A. Vincent, J. Newsom-Davis, P. Newton, and N. Beck, “Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis,” Neurology, 33, No. 10, 1276–1282 (1983).

    Article  PubMed  CAS  Google Scholar 

  31. A. Vincent, P. J. Whiting, M. Schluep, et al., “Antibody heterogeneity and specificity in myasthenia gravis,” Ann. N.Y. Acad. Sci., 505, 106–120 (1987).

    Article  PubMed  CAS  Google Scholar 

  32. R. Voltz, R. Hohlfeld, A. Faten-Moghadam, et al., “Myasthenia gravis: measurement of anti-AChR autoantibodies using cell line TE671,” Neurology, 41, 1836–1838 (1991).

    Article  PubMed  CAS  Google Scholar 

  33. G. I. Wolfe, H. J. Kaminski, A. Jaretzki, et al., “Development of a thymectomy trial in nonthymomatous myasthenia gravis patients receiving immunosuppressive therapy,” Ann. N.Y. Acad. Sci., 998, 473–480 (2003).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. G. Sanadze.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 112, No. 9, Iss. I, pp. 32–36, September, 2012.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nikishov, V.N., Bogdanov, E.I., Sanadze, A.G. et al. Thymectomy and Antibodies to Acetylcholine Receptors in Myasthenia Patients during the Early Post-Operative Period. Neurosci Behav Physi 43, 1121–1125 (2013). https://doi.org/10.1007/s11055-013-9859-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-013-9859-0

Keywords

Navigation